CTCX P/E Ratio
P/E Ratio as of Jul 25, 2025: -0.33
Average-0.2832
Median-0.2300
Minimum-0.5000
Maximum-0.2000
-0.33
Past Month-0.08 (32.00%)
The P/E ratio for CTCX is -0.33 as of Jul 25, 2025. This represents a decrease of -52.17% compared to its 12-month average P/E ratio of -0.69. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Carmell Therapeutics Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Carmell Therapeutics Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Carmell Therapeutics Corp to industry peers.
Carmell Therapeutics Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Carmell Therapeutics Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Carmell Therapeutics Corp to industry peers.
CTCX P/E Ratio Insights
See Carmell Therapeutics Corp’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in CTCX
Order type
Buy in
Order amount
Est. shares
0 shares
CTCX P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $2.45 | -0.21 |
| Jun 2, 2025 | $3.27 | -0.28 |
| May 1, 2025 | $5.265 | -0.45 |
| Apr 1, 2025 | $3.783 | -0.33 |
| Mar 3, 2025 | $6.768 | -0.41 |
| Feb 3, 2025 | $9.69 | -0.59 |
| Jan 2, 2025 | $20.763 | -1.27 |
CTCX End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.33 | -35.29% |
| 2024 | -0.51 | -92.49% |
| 2023 | -6.79 | -99.07% |
| 2022 | -731.36 | — |
FAQs About Carmell Therapeutics Corp (CTCX) P/E ratio
The latest P/E ratio of CTCX is -0.33, as of Jul 25, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Carmell Therapeutics Corp’s last 12-month average P/E ratio is -0.69, compared to its current P/E ratio of -0.33. This reflects a decrease of -52.17%.
Carmell Therapeutics Corp’s current P/E ratio of -0.33 is lower than its last 12-month average P/E of -0.69. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Carmell Therapeutics Corp’s average P/E ratio over the last 3 years is 27.3. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Carmell Therapeutics Corp’s average P/E ratio over the last 5 years is 11.04. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.